EUVIMEDEUVIMED entdecken
Crossref

The potential role of Tirzepatide as adjuvant therapy in countering colistin-induced nephro and neurotoxicity in rats via modulation of PI3K/p-Akt/GSK3-β/NF-kB p65 hub, shielding against oxidative and endoplasmic reticulum stress, and activation of p-CREB/BDNF/TrkB cascade

Noha F Hassan, Diaa Ragab, Shaimaa G Ibrahim, Mona M Abd El-Galil, Asmaa Hassan Abd-El-Hamid, Dalia M Hamed, Mira Magdy William, Maha A Salem

International Immunopharmacology · 2024-06 · 135 · 112308

DOI: 10.1016/j.intimp.2024.112308 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2024-06. Verfasst von Noha F Hassan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, Faculty of Pharmacy, Modern University for Technology and Information, Cairo, Egypt. Electronic address: N…. Hauptthemen laut MEDLINE: Brain-Derived Neurotrophic Factor, Cyclic AMP Response Element-Binding Protein, Endoplasmic Reticulum Stress, Gastric Inhibitory Polypeptide. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 88 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although colistin has a crucial antibacterial activity in treating multidrug-resistant gram-negative bacteria strains; it exhibited renal and neuronal toxicities rendering its use a challenge. Previous studies investigated the incretin hormones either glucose-dependent insulinotropic polypeptide (GIP) or glucagonlike peptide-1 (GLP-1) for their neuroprotective and nephroprotective effectiveness. The present study focused on investigating Tirzepatide (Tirze), a dual GLP-1/GIP agonist, as an adjuvant therapy in the colistin treatment protocol for attenuating its renal and neuronal complications. Rats were divided into; The normal control group, the colistin-treated group received colistin (300,000 IU/kg/day for 7 days; i.p.). The Tirze-treated group received Tirze (1.35 mg/kg on the 1,4,7thdays; s.c.) and daily colistin. Tirze effectively enhanced histopathological alterations, renal function parameters, and locomotor activity in rats. Tirze mechanistically acted via modulating various signaling axes evolved under the insult of phosphatidylinositol 3-kinases (PI3K)/phosphorylated protein kinase-B (p-Akt)/ glycogen synthase kinase (GSK)3-β hub causing mitigation of nuclear factor (NF)-κB (NF-κB) / tumor necrosis factor-α (TNF-α), increment of nuclear factor erythroid 2-related factor 2 (Nrf2)/ glutathione (GSH), downregulation of ER stress-related biomarkers (activation transcription factor 4 (ATF4) and C/EBP homologous protein (CHOP)), antiapoptotic effects coupling with reduction of glial fibrillary acidic protein (GFAP) immunoreactivity and enhancement of phosphorylated c-AMP response element-binding (p-CREB) / brain-derived neurotrophic factor (BDNF)/tyrosine kinase B (TrkB) neuroprotective pathway. Briefly, Tirze exerts a promising role as adjuvant therapy in the colistin treatment protocol for protection against colistin's nephro- and neurotoxicity according to its anti-inflammatory, antioxidant, and antiapoptotic impacts besides its ability to suppress ER stress-related biomarkers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brain-Derived Neurotrophic FactorCyclic AMP Response Element-Binding ProteinEndoplasmic Reticulum StressGastric Inhibitory PolypeptideGlycogen Synthase Kinase 3 betaKidneyKidney DiseasesOxidative StressProto-Oncogene Proteins c-aktSignal TransductionGlucagon-Like Peptide-1 Receptor AgonistsAnimalsRatsAnti-Bacterial AgentsColistinNeuroprotective AgentsNeurotoxicity SyndromesPhosphatidylinositol 3-KinasesRats, WistarReceptor, trkBTirzepatideGlucagon-Like Peptide-1 Receptor

Stichwörter der Autor:innen

ColistinER stressNephrotoxicityNeurotoxicityPI3K/p-Akt/GSK3-βTirzepatide

Substanzen

Anti-Bacterial AgentsBrain-Derived Neurotrophic FactorColistinCyclic AMP Response Element-Binding ProteinGastric Inhibitory PolypeptideGlycogen Synthase Kinase 3 betaNeuroprotective AgentsPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktReceptor, trkB

Autor:innen und Institutionen

  • Department of Pharmacology and Toxicology, Faculty of Pharmacy, Modern University for Technology and Information, Cairo, Egypt. Electronic address: Noha.Fawzy@pharm.mti.edu.eg.
  • Department of Pharmacology and Toxicology, Faculty of Pharmacy, University of Sadat City, Menoufia, Egypt.
  • Department of Pharmacology and Toxicology, Faculty of Pharmacy, October 6 University, Giza, Egypt.
  • Department of Histology and Cell Biology, Faculty of Medicine for Girls, Al-Azhar University, Cairo, Egypt.
  • Department of Microbiology and Immunology, Faculty of Pharmacy, Modern University for Technology and Information, Cairo, Egypt.
  • Department of Biochemistry, Faculty of Pharmacy, October 6 University, Giza, Egypt.

Zitieren

APA

Hassan, N. F., Ragab, D., Ibrahim, S. G., Abd El-Galil, M. M., Hassan Abd-El-Hamid, A., Hamed, D. M., Magdy William, M., & Salem, M. A. (2024). The potential role of Tirzepatide as adjuvant therapy in countering colistin-induced nephro and neurotoxicity in rats via modulation of PI3K/p-Akt/GSK3-β/NF-kB p65 hub, shielding against oxidative and endoplasmic reticulum stress, and activation of p-CREB/BDNF/TrkB cascade. International Immunopharmacology, 135, 112308. https://doi.org/10.1016/j.intimp.2024.112308

Vancouver

Hassan NF, Ragab D, Ibrahim SG, Abd El-Galil MM, Hassan Abd-El-Hamid A, Hamed DM, et al. The potential role of Tirzepatide as adjuvant therapy in countering colistin-induced nephro and neurotoxicity in rats via modulation of PI3K/p-Akt/GSK3-β/NF-kB p65 hub, shielding against oxidative and endoplasmic reticulum stress, and activation of p-CREB/BDNF/TrkB cascade. International Immunopharmacology. 2024;135:112308. doi:10.1016/j.intimp.2024.112308

BibTeX
@article{Hassan2024,
  author = {Hassan, Noha F and Ragab, Diaa and Ibrahim, Shaimaa G and Abd El-Galil, Mona M and Hassan Abd-El-Hamid, Asmaa and Hamed, Dalia M and Magdy William, Mira and Salem, Maha A},
  title = {The potential role of Tirzepatide as adjuvant therapy in countering colistin-induced nephro and neurotoxicity in rats via modulation of PI3K/p-Akt/GSK3-β/NF-kB p65 hub, shielding against oxidative and endoplasmic reticulum stress, and activation of p-CREB/BDNF/TrkB cascade},
  journal = {International Immunopharmacology},
  year = {2024},
  volume = {135},
  pages = {112308},
  doi = {10.1016/j.intimp.2024.112308}
}
Kostenlos starten →